EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Personalization of pharmacotherapy with sirolimus based on volumetric absorptive microsampling (VAMS) in pediatric renal transplant recipients—from LC-MS/MS method validation to clinical application

Arkadiusz Kocur iD, Agnieszka Czajkowska iD, Kamila Rębis, Jacek Rubik iD, Mateusz Moczulski iD, Bartłomiej Kot, Maciej Sierakowski, Tomasz Pawiński iD

Pharmacological Reports · 2024

DOI: 10.1007/s43440-024-00663-9 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Pharmacological Reports, 2024. Verfasst von Arkadiusz Kocur und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Chemistry, Pharmaceutical and Biomedical Analysis, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, Warsaw, 02-097, P…. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Kidney Transplantation, Drug Monitoring, Sirolimus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Warszawski Uniwersytet Medyczny, Instytut Pomnik - Centrum Zdrowia Dziecka.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The benefits of pharmacotherapy with sirolimus (SIR) in pediatric transplant recipients are well established. Traditionally, whole blood samples have been used to measure SIR concentrations. Volumetric Absorptive Microsampling (VAMS) is an alternative sampling strategy suitable for Therapeutic Drug Monitoring (TDM). In this study, we developed and validated two liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods for determining SIR concentrations in whole blood (WB) and capillary whole blood samples collected using a VAMS-Mitra™ device.

Methods

We used protein precipitation during WB sample preparation and dispersive liquid-liquid microextraction (DLLME) with methyl tert-butyl ether for VAMS sample preparation to optimise the analyte extraction process. The described validation protocols were cross-validated, confirming the equivalence of the whole-blood and VAMS-based methods. Furthermore, the developed methods were evaluated in two three-level rounds of an external proficiency-testing scheme.

Results

The analytical methods were successfully validated within the calibration range of SIR (0.5–60 ng/ml). The validation parameters met the European Medicines Agency (EMA) and the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDM&CT) acceptance criteria. No hematocrit (tested in the range of 24.3–64.1%), matrix, or carry-over effects were observed. Cross-validation confirmed the interchangeability between VAMS-LC-MS/MS and WB-LC-MS/MS methods. The developed methods were successfully implemented for SIR determination in 140 clinical samples (70 each of WB and VAMS) from pediatric renal transplant recipients, demonstrating their practicality and reliability.

Conclusion

The VAMS-based method has been rigorously tested and is clinically equivalent to the reference WB-LC-MS/MS method. Additionally, clinical validation confirmed the utility of the presented methods for TDM of the SIR in the pediatric population after renal transplantation. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryKidney TransplantationDrug MonitoringSirolimusImmunosuppressive AgentsHumansChildChromatography, LiquidPrecision MedicineBlood Specimen CollectionTransplant RecipientsChild, PreschoolLiquid Phase MicroextractionMaleAdolescentLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

DLLMELC-MS/MSPediatricsRapamycinSirolimusVAMS

Substanzen

SirolimusImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Drug Chemistry, Pharmaceutical and Biomedical Analysis, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, Warsaw, 02-097, Poland. arkadiusz.kocur@wum.edu.pl.
  • Therapeutic Drug Monitoring, Clinical Pharmacokinetics and Toxicology Laboratory Unit, Department of Clinical Biochemistry, The Children's Memorial Health Institute, Dzieci Polskich 20, Warsaw, 04-730, Poland. arkadiusz…
  • Therapeutic Drug Monitoring, Clinical Pharmacokinetics and Toxicology Laboratory Unit, Department of Clinical Biochemistry, The Children's Memorial Health Institute, Dzieci Polskich 20, Warsaw, 04-730, Poland.
  • Department of Drug Chemistry, Pharmaceutical and Biomedical Analysis, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, Warsaw, 02-097, Poland.
  • Department of Nephrology, Kidney Transplantation and Arterial Hypertension, The Children's Memorial Health Institute, Dzieci Polskich 20, Warsaw, 04-730, Poland.
  • Institute of Biological Sciences, Cardinal Stefan Wyszynski University, Kazimierza Wóycickiego 1/3, Warsaw, 01-938, Poland.

ORCID-Profile: Arkadiusz Kocur, Agnieszka Czajkowska, Jacek Rubik, Mateusz Moczulski, Tomasz Pawiński

Förderung

  • Warszawski Uniwersytet Medyczny
  • Instytut Pomnik - Centrum Zdrowia Dziecka

Zitieren

APA

Kocur, A., Czajkowska, A., Rębis, K., Rubik, J., Moczulski, M., Kot, B., Sierakowski, M., & Pawiński, T. (2024). Personalization of pharmacotherapy with sirolimus based on volumetric absorptive microsampling (VAMS) in pediatric renal transplant recipients—from LC-MS/MS method validation to clinical application. Pharmacological Reports. https://doi.org/10.1007/s43440-024-00663-9

Vancouver

Kocur A, Czajkowska A, Rębis K, Rubik J, Moczulski M, Kot B, et al. Personalization of pharmacotherapy with sirolimus based on volumetric absorptive microsampling (VAMS) in pediatric renal transplant recipients—from LC-MS/MS method validation to clinical application. Pharmacological Reports. 2024. doi:10.1007/s43440-024-00663-9

BibTeX
@article{Kocur2024,
  author = {Kocur, Arkadiusz and Czajkowska, Agnieszka and Rębis, Kamila and Rubik, Jacek and Moczulski, Mateusz and Kot, Bartłomiej and Sierakowski, Maciej and Pawiński, Tomasz},
  title = {Personalization of pharmacotherapy with sirolimus based on volumetric absorptive microsampling (VAMS) in pediatric renal transplant recipients—from LC-MS/MS method validation to clinical application},
  journal = {Pharmacological Reports},
  year = {2024},
  doi = {10.1007/s43440-024-00663-9}
}
Kostenlos starten →